Pathophysiology of Rejection in Kidney Transplantation
- PMID: 37373823
- PMCID: PMC10299312
- DOI: 10.3390/jcm12124130
Pathophysiology of Rejection in Kidney Transplantation
Abstract
Kidney transplantation has been the optimal treatment for end-stage kidney disease for almost 70 years, with increasing frequency over this period. Despite the prevalence of the procedure, allograft rejection continues to impact transplant recipients, with consequences ranging from hospitalization to allograft failure. Rates of rejection have declined over time, which has been largely attributed to developments in immunosuppressive therapy, understanding of the immune system, and monitoring. Developments in these therapies, as well as an improved understanding of rejection risk and the epidemiology of rejection, are dependent on a foundational understanding of the pathophysiology of rejection. This review explains the interconnected mechanisms behind antibody-mediated and T-cell-mediated rejection and highlights how these processes contribute to outcomes and can inform future progress.
Keywords: T-cell-mediated rejection; allograft rejection; antibody-mediated rejection; kidney transplant; transplant immunology.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Figures
References
-
- United Network for Organ Sharing Data and Trends. 2023. [(accessed on 14 April 2023)]. Available online: https://unos.org/data/
-
- Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y.C., Held P.J., Port F.K. Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant. N. Engl. J. Med. 1999;341:1725–1730. doi: 10.1056/NEJM199912023412303. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical
